dndi astmh 2014
Post on 29-Nov-2021
6 Views
Preview:
TRANSCRIPT
DNDi @ ASTMH 2014Drugs for Neglected Diseases initiative (DNDi ) presentations
at the American Society of Tropical Medicine and Hygiene (ASTMH), 63rd Annual Meeting
NoveMber 2-6, 2014
Sheraton New Orleans Hotel and New Orleans Marriott Hotel
New orleans, LA
Drugs for Neglected Diseases initiative, North America40 Wall Street, 24th Floor – New York, NY 10005Telephone: +1.646.616.8680Email: dndina@dndi.org
www.dndi.org
Follow us!Facebook: facebook.com/dndi.org
Twitter: @DNDi_HQ
Drugs for Neglected Diseases initiative (DNDi) American Society of Tropical Medicine and Hygiene (ASTMH)
NoveMber 2-6, 2014 • New orLeANS http://bit.ly/DNDiASTMH2014
Visit us at the DNDi Booth! #307
DNDi @ ASTMH 2014
Monday, November 3rd, 2014
> POSTER (498)Oral flubendazole: a potentially useful macrofilaricide• DNDi Author: Ivan Scandale• Session title: 28: Poster Session A • Session time: 12:00 -1:45 PM• Location: New Orleans Marriott
Grand Ballroom, 3rd Floor
> SIDE EVENTChanging the face of chagas disease• Event time: 6:00 PM• Location (OFF SITE): Tulane
University School of Public Health and Tropical Medicine, Collins C. Diboll Gallery & Auditorium, 1440 Canal Street
• Sponsors: Sabin Vaccine Institute, the National School of Tropical Medicine at Baylor College of Medicine, DNDi, MSF, the Global Chagas Disease Coalition, ASTMH and PAHO
• Link: http://bit.ly/FaceOfChagas
Tuesday, November 4th, 2014
> ORAL (1483)Efficacy, safety and population pharmacokinetics of the artesunate mefloquine (ASMQ) fixed dose combination versus artemether lumefantrine for the treatment of uncomplicated falciparum malaria in African children
• DNDi Authors: Joelle Vanraes, Nathalie Strub-Wourgaft, Gwenaelle Carn
• Session title: 64: Malaria: Drug Development - New Approaches, Efficacy, Safety and Pharmacology
• Session time: 8:00 - 9:45 AM• Location: Sheraton New Orleans
Grand Ballroom D, 5th Floor
> ORAL (1209)Drug discovery and development for the treatment and control of filariasis: repurposing emodepside• DNDi Authors: Robert Don,
Ivan Scandale• Session title: 108: Filariasis:
Clinical• Session time: 4:00 - 5:45 PM• Location: New Orleans Marriott
Mardi Gras Ballroom D, 3rd Floor
Wednesday, November 5th, 2014
> POSTER (1459)The AMFm in Ghana: factors associated with private retailers: adherence to the recommended retail price• DNDi Author: Graciela Diap• Session title: 140: Poster
Session C• Session time: 12:00 - 1:45 PM• Location: New Orleans Marriott
Grand Ballroom, 3rd Floor
> SyMPOSIuM (153)New treatments for kinetoplastid diseases
that can be easily delivered in rural health posts: where are we now?• DNDi Presenter: Nathalie
Strub-Wourgaft• Session title: Transitioning from
the vertical to the horizontal: Challenges in integrating diagnosis and treatment of kinetoplastid diseases in essential health services
• Session time: 1:45 - 3:30 PM• Location: New Orleans Marriott
Mardi Gras Ballroom D, 3rd Floor
> SyMPOSIuM (64)Towards the elimination of human African trypanosomiasis (HAT)• Details: Chair: Jose Ramon
Franco Minguell (WHO); Co-chair: Crispin Lumbala (PNLTHA)
4:00 PM Veerle Lejon (IRD): Advances and challenges in current diagnostics for HAT
4:20 PM Antoine Tarral (DNDi ): New oral treatments for HAT
4:40 PM Wilfried Mutombo (PNLTHA): Implementation of studies in remote areas in countries with limited regulatory and ethics experience
5:00 PM Jose Ramon Franco Minguell (WHO): How to achieve HAT elimination with current and new tools
• Session time: 4:00 - 5:45 PM• Location: New Orleans Marriott
Grand Ballroom FGH, 3rd Floor
top related